The clinical diagnosis of MNGIE disease is based on the presence of the major clinical characteristics or by detection of pathogenic mutations in TYMP, reduced levels of thymidine phosphorylase enzyme activity, or elevated plasma concentrations of deoxyuridine and thymidine [3]. Here, TYMP is linked to mitochondrial neurogastrointestinal encephalomyopathy.